SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-010251
Filing Date
2022-03-21
Accepted
2022-03-18 18:03:51
Documents
12
Period of Report
2022-03-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10035425_8k.htm   iXBRL 8-K 33077
  Complete submission text file 0001140361-22-010251.txt   169017

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20220317.xsd EX-101.SCH 3932
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20220317_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20220317_pre.xml EX-101.PRE 16048
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10035425_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 22753742
SIC: 2834 Pharmaceutical Preparations